Orthofix Medical Inc. Stockholders Equity

Quick Answer

Orthofix Medical Inc. reported Stockholders Equity of $450.04 million for the year ending 2025.

  • Orthofix Medical Inc. showed a decrease of -10.6% in Stockholders Equity from 2024 to 2025.
  • This data is from Orthofix Medical Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: $290.54 million | Q2 2015: $297.68 million | Q3 2015: $297.21 million | Q1 2016: $275.47 million | Q2 2016: $258.23 million | Q3 2016: $273.18 million | Q1 2017: $267.13 million | Q2 2017: $276.95 million | Q3 2017: $285.31 million | Q1 2018: $313.17 million | Q2 2018: $319.85 million | Q3 2018: $323.35 million | Q1 2019: $343.68 million | Q2 2019: $347.79 million | Q3 2019: $306.43 million | Q1 2020: $355.37 million | Q2 2020: $345.05 million | Q3 2020: $354.90 million | Q1 2021: $354.82 million | Q2 2021: $362.28 million | Q3 2021: $364.83 million | Q1 2022: $335.58 million | Q2 2022: $341.95 million | Q3 2022: $333.54 million | Q1 2023: $664.16 million | Q2 2023: $639.99 million | Q3 2023: $615.48 million | Q1 2024: $570.32 million | Q2 2024: $546.00 million | Q3 2024: $525.92 million | Q1 2025: $458.29 million | Q2 2025: $458.35 million | Q3 2025: $442.49 million.
  • Over the full 17 years of available data (2013 to 2025), Orthofix Medical Inc.'s Stockholders Equity has grown by 41.1%.
  • Historical annual values: Fiscal year 2025: $450.04 million | Fiscal year 2024: $503.12 million | Fiscal year 2023: $598.73 million | Fiscal year 2022: $336.86 million | Fiscal year 2021: $336.93 million | Fiscal year 2020: $356.86 million | Fiscal year 2019: $327.63 million | Fiscal year 2018: $335.40 million | Fiscal year 2017: $296.61 million | Fiscal year 2016: $263.48 million | Fiscal year 2015: $290.31 million | Fiscal year 2014: $299.63 million | Fiscal year 2014: $305.02 million | Fiscal year 2014: $305.21 million | Fiscal year 2014: $300.56 million | Fiscal year 2013: $295.86 million | Fiscal year 2013: $319.06 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: